Molecule for treating an inflammatory disorder

Details for Australian Patent Application No. 2010335039 (hide)

Owner Prosensa Technologies B.V. Academisch Ziekenhuis Leiden h.o.d.n. LUMC

Inventors Van Ommen, Garrit-Jan Boudewijn; Aartsma-Rus, Annemieke; Van Deutekom, Judith Christina Theodora; De Kimpe, Josephus Johannes; Verbeek, Joseph Stephan; Yilmaz-Elis, Aliye Seda

Agent Freehills

Pub. Number AU-A-2010335039

PCT Pub. Number WO2011/078672

Priority 61/290,102 24.12.09 US; 09180760.2 24.12.09 EP

Filing date 22 December 2010

Wipo publication date 30 June 2011

International Classifications

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/078672 Priority application(s): WO2011/078672

26 July 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 26 Jun 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010335043-New use of pulsed radio frequency

2010335005-Treatment of bone fracture